澳门威士尼斯人(SViP认证)网站-Win win Platform
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
旧版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Notice of Extraordinary General Meeting
2024-10-03
Proposed Amendments to the Articles of Association, the Rules and Procedures for General Meetings,Board Meetings and Supervisors Meetings and Notice of Extraordinary General Meeting
2024-10-03
Proposed Amendments to the Articles of Association and Relevant Rules and Procedures
2024-09-30
Overseas Regulatory Announcement-Announcement on Having Obtained the Notification of Approval of Supplementary Drug Application and Other Relevant Information
2024-09-13
Overseas regulatory announcement-Announcement on Obtaining Approval Notice for Supplementary Drug Application and Other Relevant Information
2024-09-03
Overseas Regulatory Announcement-Announcement on Esomeprazole Magnesium Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
2024-09-02
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2024
2024-09-02
Overseas Regulatory Announcement-Announcement on the Progress of Clinical Trial of OAB-14 Dry Suspension
2024-08-22
Interim Dividend For the Six Months Ended 30 June 2024
2024-08-22
Payment of 2024 Interim Dividend
2024-08-22
<
1
2
3
4
5
6
7
...
>